|
| 甘李药业(603087)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-05-26 | 211.20 | 0.35% | 55721.90 | 4384.63 | 54813.99 | 91.19% | 股权激励限售股份 | | 2024-12-20 | 118.92 | 0.20% | 55510.70 | 4595.83 | 54813.99 | 91.19% | 股权激励限售股份 | | 2024-10-31 | 577.79 | 0.96% | 55391.78 | 4714.75 | 54813.99 | 91.19% | 首发原股东限售股份 | | 2024-10-17 | 1587.58 | 2.64% | 54813.99 | 5292.54 | 53226.41 | 88.55% | 首发原股东限售股份 | | 2024-05-10 | 118.92 | 0.20% | 53226.41 | 6189.77 | 53107.49 | 89.38% | 股权激励限售股份 | | 2023-06-29 | 23085.29 | 40.81% | 53107.49 | 3457.83 | 29686.22 | 52.48% | 首发原股东限售股份 | | 2023-05-22 | 335.98 | 0.59% | 30022.20 | 26543.12 | 29686.22 | 52.48% | 首发原股东限售股份 | | 2023-01-31 | 108.93 | 0.19% | 29686.22 | 26879.10 | 29686.22 | 52.48% | 首发原股东限售股份 | | 2022-08-15 | 335.98 | 0.60% | 29577.28 | 26576.72 | 29577.28 | 52.67% | 首发原股东限售股份 | | 2022-03-04 | 360.83 | 0.64% | 29241.31 | 26912.69 | 29241.31 | 52.07% | 首发原股东限售股份 | | 2022-01-21 | 25.94 | 0.05% | 28880.48 | 27273.52 | 28880.48 | 51.43% | 首发原股东限售股份 | | 2021-06-29 | 23200.60 | 41.32% | 28828.60 | 27325.40 | 56154.00 | 100.00% | 发行前股份限售流通 |
|